Literature DB >> 9427709

The low-density lipoprotein receptor-related protein (LRP) mediates clearance of coagulation factor Xa in vivo.

M Narita1, A E Rudolph, J P Miletich, A L Schwartz.   

Abstract

Blood coagulation factor X plays a pivotal role in the clotting cascade. When administered intravenously to mice, the majority of activated factor X (factor Xa) binds to alpha 2-macroglobulin (alpha 2M) and is rapidly cleared from the circulation into liver. We show here that the low-density lipoprotein receptor-related protein (LRP) is responsible for factor Xa catabolism in vivo. Mice overexpressing a 39-kD receptor-associated protein that binds to LRP and inhibits its ligand binding activity displayed dramatically prolonged plasma clearance of 125I-factor Xa. Preadministration of alpha 2M-proteinase complexes (alpha 2M*) also diminished the plasma clearance of 125I-factor Xa in a dose-dependent fashion. The clearance of preformed complexes of 125I-factor Xa and alpha 2M was similar to that of 125I-factor Xa alone and was also inhibited by mice overexpressing a 39-kD receptor-associated protein. These results thus suggest that, in vivo, factor Xa is metabolized via LRP after complex formation with alpha 2M.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427709

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B.

Authors:  Dawei Wang; Xiaohu Shao; Qiang Wang; Xiaohong Pan; Yujun Dai; Shuxian Yao; Tong Yin; Zhugang Wang; Jiang Zhu; Xiaodong Xi; Zhu Chen; Saijuan Chen; Guowei Zhang
Journal:  Clin Transl Med       Date:  2021-03

2.  Coagulation factor X interaction with macrophages through its N-glycans protects it from a rapid clearance.

Authors:  Mohamad Kurdi; Ghislaine Cherel; Peter J Lenting; Cécile V Denis; Olivier D Christophe
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.